Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMR1964 (Insulin Glulisine) in T2DM Not Controlled with OHA
NCT00290927Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2003
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glulisine in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Dec 2003; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00290927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00290927.